Skip to main content
Caplight Logo









Suki

Suki

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.suki.ai/

Last Round

Series E

Oct 12, 2026

Est. Valuation

$500M

Total Funding Raised

$258M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Suki is a healthtech company that provides an AI-powered voice assistant and ambient clinical intelligence platform designed to streamline administrative tasks and clinical documentation for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Medical AI, NLP & Conversational AI, Workflow Automation, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

ambient clinical intelligenceclinical documentationAI scribeelectronic health recordsEHRclinical decision supportphysician burnoutvoice-enabled AIhealthcare AIworkflow automationambient AImedical scribe AISaaS healthcareprior authorizationconversational AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suki Comparables

Compare Suki with similar companies based on industry and business-model similarity.

Suki comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DeepScribe
90%
Ambience Healthcare
87%
Abridge Inc
86%

Suki Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EOct 12, 2026
Series D ExtensionJan 30, 2025
Series DOct 10, 2024
Series CDec 7, 2021
Series BMar 4, 2020
Series A
May 1, 2018

Key People

Founding team and executive leadership

Joe Chang

CTO

Executive Team

Bryan Morris

Chief Financial Officer

Executive Team

Abhi Pathak

Chief Product Officer

Executive Team

Suki Investors

Notable investors and investment history

Suki investors
InvestorRounds
Hercules CapitalSeries E
Breyer CapitalSeries C, Series D, Series B
Epsilon Health InvestorsSeries B
Philips VenturesSeries E, Series C
Crosslink CapitalSeries E
GaingelsSeries C
Inhealth VenturesSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 12, 2026

    $90M round with participation from Venrock and Philips Ventures.

  • Aug 22, 2026

    Monthly visitors increased 31% MoM.

Recent news

Latest coverage and updates

  • is_developingOct 16, 2026

    Suki plans to use funding to develop AI agents capable of handling referrals, prior authorizations and follow-up scheduling.

  • hiresOct 14, 2026

    Suki adds Healthier Capital Partner Aman Mahajan to its board as part of the transaction, bringing a physician and health-system leader into its board discussions.

  • is_developingOct 13, 2026

    Suki plans to develop AI agents that handle post-visit tasks such as coordinating referrals and managing medication prior authorisations, using information from its existing tools.

  • launchesOct 13, 2026

    Suki launches a new AI capability less than a week before its $90 million Series E raise.

  • receives_financingOct 13, 2026

    Suki secures $90M in Series E financing from Healthier Capital, Crosslink Capital, Hercules Capital, and existing institutional investors to accelerate growth and expand its healthcare AI platform on Oct 14th '26.

Suki Filings

Explore SEC and related filing metadata, where available.

Suki filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Suki's valuation, stock price, and market status.

Is Suki a public or private company?

Suki is a private company.

What is the current stock price of Suki?

Suki is a private company, so its shares have no public market price. Caplight tracks Suki's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Suki worth (valuation)?

Suki's valuation is estimated at $500.0M based on funding round data.

Can I buy Suki stock?

Suki shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Suki's last funding round?

Suki's most recent funding round was Series E on October 12, 2026.

Who are the main investors in Suki?

Key investors in Suki include Flare Capital Partners, Social Capital, Hedosophia, Zoom Ventures, March Capital.

Will Suki IPO soon?

No public IPO plans have been announced for Suki.

How can I track Suki secondary market activity?

Caplight tracks bids, offers, and trades in Suki's shares on secondary markets.

Firmographic Details

HeadquartersRedwood City, California
Employee Range275
Year Founded2017
Last FundingOct 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?